Retrospective study evaluates perioperative haemodynamic markers for predicting RV failure, suggesting improved risk assessment.
OBJECTIVES: Right ventricular failure (RVF) remains a frequent complication following Left Ventricular Assist Device (LVAD) implantation. Conventional risk scores rely on preoperative data acquired under stable conditions, which may overlook early signs of RV decompensation that emerge under perioperative stress. This study evaluates whether perioperative haemodynamic markers prior to cardiopulmonary bypass (CPB) improve RVF prediction compared to preoperative assessment obtained by right heart catheterisation (RHC), echocardiographic parameters and scoring systems such as the EUROMACS-RHF score. METHODS: We conducted a retrospective single-centre study of 203 LVAD patients (2013-2023). The primary outcome was RVF. Preoperative data included clinical variables, echocardiography, and RHC. Perioperative data included vasoactive-inotropic score (VIS), pulmonary artery catheter and arterial-line monitoring between induction and start of CPB. Two multivariable models were developed using LASSO logistic regression: (1) Preoperative model; (2) Pre-CPB model. Model performance was assessed using area-under-the-curve (AUC), and compared against EUROMACS-RHF using DeLong tests. RESULTS: 36 patients (17.7%) developed RVF. No preoperative RHC-derived parameter independently predicted RVF. The Preoperative model achieved moderate discrimination (AUC: 0.747). Incorporating intraoperative mean arterial pressure (MAP), pulmonary artery pulsatility index (PAPi) and maximum VIS, yielded a Pre-CPB model with strong discrimination (AUC: 0.834). The Pre-CPB model significantly outperformed both EUROMACS-RHF (p = 0.0299) and the Preoperative model (p = 0.049), with no significant difference between our Preoperative model and EUROMACS-RHF (p = 0.222). CONCLUSIONS: Perioperative markers prior to CPB significantly outperform preoperative prediction of RVF post-LVAD. Incorporating these into real-time risk stratification can improve decision-making, enabling earlier RV support in the operating theatre for high-risk LVAD patients.
No takes yet. Share an insight, caveat, or question.
Rajendra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: